(Photo Credit - Stephen Charles Thompson)
Based on a recent press release, United Cannabis Corp. (OTC:CNAB) was recently granted United States Patent No.: 9,730,911 (“the ‘911 Patent”) on “Cannabis Extracts and Methods of Preparing and Using Same” on August 15, 2017. This patent covers United Cannabis Corp.’s Prana Bio Nutrient Line of products.
Related: Cannabis I.P. in Focus - United Cannabis Corp.
The ‘911 Patent covers three types of liquid cannabinoid formulations: (1) a formulation where at least 95% of the total cannabinoids in the formulation is THCa; (2) a formulation where at least 95% of the total cannabinoids in the formulation are THCa and CBDa; and (3) a formulation where at least 95% of the total cannabinoids in the formulation are THC, CBD, and CBN.
Related: There's Over 100 Different Cannabinoids
To me, the ‘911 Patent offers United Cannabis Corp a broad scope of protection over liquid cannabinoid formulations that have high concentrations of THCa and CBDa. As the therapeutic effects of these compounds become better studied, the ‘911 Patent will pay continued dividends to United Cannabis Corp.
Related: Marijuana Stocks Paying Dividends
For those of you who read my last article on United Cannabis Corp’s intellectual property, this may seem familiar. For those of you who haven’t, I recommend giving it a read, but the tl;dr is that United Cannabis Corp’s is seeking international protection (via a PCT application) on various cannabinoid formulations that are rich in THCa, CBDa, CBNa, CBCa, THC, CBN, CNB, and/or CBC, among other things.
Related: What is CBG (Cannabigerol)?
Interestingly, the ‘911 Patent is not part of United Cannabis Corp.’s PCT application discussed in my last article. However, both the ‘911 Patent and the PCT claim priority to United States Provisional Patent Applications 62/068,278 and 62/066,795, which means that they share common subject matter.
Related: Protecting Your cannabis Company's I.P.
The implication of the ‘911 Patent being related to the PCT application, is that the issuance of the ‘911 Patent will have implications on the various National Phase entries of the PCT. Many foreign patent offices look to how the United States and Europe analyze a given patent application, and give credence to the findings of those offices. In short, United Cannabis Corp. will likely receive the international protection that they are seeking. The exact scope of what is granted in each country remains to be seen, but I would say things are looking positively for United Cannabis Corp.’s IP portfolio.
Related: The First Marijuana Strain Patent Ever Granted
Be sure to subscribe to The Daily Marijuana Observer's Cannabis Legal Newsletter below so you never miss an important intellectual property update.
About the Author: Matthew G. Miller, Esq. is Principal and Patent Attorney at MG Miller Intellectual Property Law LLC. Matt received formal training in chemistry at the University of Chicago, is very passionate about innovations in high technology, and is an amateur computer programmer. He uses this combination to develop creative, effective, and efficient intellectual property portfolios.